Role of the Multidisciplinary Team in Achieving Comprehensive and Individualized Care of Patients with HR-positive/HER2-negative Metastatic Breast Cancer and Preexisting Comorbidities

Decera Clinical Education Oncology Podcast · May 29, 2025 · 35:15

Listen in the Podli app 🎧

Follow your favourite podcasts, listen offline and in the car with CarPlay and Android Auto, and always pick up where you left off. Free to try.

In this podcast episode, Sara A. Hurvitz, MD, FACP, La-Urshalar B. Brock, FNP-BC, CNM, and Jordan Hill, PharmD, BCOP, discuss the important role of the multidisciplinary team in achieving comprehensive and individualized care of patients with HR-positive/HER2-negative metastatic breast cancer and preexisting comorbidities, including:

Key Comorbidities in Patients with HR+/HER2- MBC
Impact of Polypharmacy
Role of APPs in Comprehensive Care
Role of CDK4/6 Inhibitors and Other Treatments for HR+/HER2- MBC
Utility of RWE data
Communicating Treatment Options With Patients and Caregivers
Understanding Patient Goals and Coordinating With the Multidisciplinary Team to Individualize Treatment and Maximize Quality of Life

Link to full program:
https://bit.ly/4jCQe38

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.